MRP ₹9374
(Inclusive of all Taxes)
₹1406.1 Cashback (15%)
Provide Delivery Location
About Mabvinra 40 mg Injection
Mabvinra 40 mg Injection belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors that help reduce signs and symptoms of autoimmune disorders. It is primarily used in the treatment of rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, plaque psoriasis, and psoriatic arthritis. This medicine is also used in the treatment of Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, and uveitis.
Mabvinra 40 mg Injection consists of Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain caused by various autoimmune diseases.
Mabvinra 40 mg Injection may cause certain side effects such as nausea, headache, back pain, upper respiratory tract infections, vision problems, dizziness, pale skin, numbness, chest pain, rash, and injection site reactions. Most of these side effects do not require medical attention or resolve over time. However, if these side effects persist for longer, please consult your doctor on priority. Mabvinra 40 mg Injection is a parenteral medicine. It will be administered by a trained healthcare doctor. Hence, do not self-administer. Your physician will decide the dose and duration of the medicine based on the type and severity of the condition.
Mabvinra 40 mg Injection should be avoided if you are allergic to any of its components. Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, hepatitis B virus infection, heart failure, liver, heart, or kidney diseases, or a weak immune system, as it can worsen your health condition. Mabvinra 40 mg Injection may cause dizziness, so drive only if you are alert and focused. Mabvinra 40 mg Injection should not be given to children under two years of age as safety has not been established. Consult the doctor if you are pregnant or breastfeeding.
Uses of Mabvinra 40 mg Injection
Mabvinra 40 mg Injection is used in the treatment of autoimmune inflammatory diseases. The detailed uses of Mabvinra 40 mg Injection are as follows:

Have a query?
Directions for Use
Medicinal Benefits
Mabvinra 40 mg Injection consists of Adalimumab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.
How Mabvinra 40 mg Injection Works
Storage
What if I have taken an overdose of Mabvinra 40 mg Injection
Drug Warnings
Mabvinra 40 mg Injection should be avoided if allergic to it or any other components present. Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, hepatitis B virus infection, heart failure, liver, heart or kidney diseases, weak immune system, multiple sclerosis (nerve and muscle disease), or diabetes as it can worsen your health condition. Do not take live vaccines while being treated with Mabvinra 40 mg Injection to prevent any serious consequences. Mabvinra 40 mg Injection is not recommended for use in children below two years of age as safety and efficacy are not established. This medicine is not recommended for patients suffering from sepsis as it can worsen the condition.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXCipla Ltd
₹18000
(₹14760.0 per unit)
RXHetero Drugs Ltd
₹23437.5
(₹24023.5/ 1ml)
RXIpca Laboratories Ltd
₹25000
(₹25625.0/ 1ml)
Alcohol
Consult your doctor
It is not known if alcohol interacts with Mabvinra 40 mg Injection . Please consult the doctor.
Pregnancy
Caution
If you are pregnant or planning pregnancy, inform your doctor before receiving Mabvinra 40 mg Injection . Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
If you are breastfeeding, inform your doctor before receiving Mabvinra 40 mg Injection .
Driving
Caution
Mabvinra 40 mg Injection will be administered in the hospital setting. Hence, driving is not recommended.
Liver
Caution
Mabvinra 40 mg Injection should be used with caution if you have liver disease. Dose adjustment may be needed in patients with liver impairment.
Kidney
Caution
Mabvinra 40 mg Injection should be used with caution if you have kidney disease. Dose adjustment may be needed in patients with liver impairment.
Children
Caution
Mabvinra 40 mg Injection is not recommended in children below two years of age as safety and efficacy are not established. In children above two years of age, it will be administered by the pediatrician. Mabvinra 40 mg Injection is used in children only for the treatment of juvenile idiopathic arthritis, paediatric Crohn’s disease, and uveitis.
Heart
Mabvinra 40 mg Injection may not be safe for heart patients. Therefore, please inform your doctor if you have any pre-existing heart conditions.
Geriatrics
Consult your doctor
Limited information available about the use of Mabvinra 40 mg Injection in geriatric patients. Please consult your physician.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information